Triangle
AI NativeTriangle helps people navigate complex diagnoses and discover emerging treatments with AI.
Est 2024|Valuation $25M|Raised $4M
Published Oct 13, 2026
Searches did not surface Triangle listings or reviews on G2, TrustRadius, Capterra, or Gartner Peer Insights that were accessible and clearly about the vendor's website. As a result, available evidence is limited and comes from app store listings, vendor-published materials, and public social posts.
A separate entity with a similar name hosts patient testimonials related to chiropractic services; this is not the same organization and should not be conflated with the vendor's website.
Third-party domain scanners and site-safety tools rate the vendor's website as likely legitimate based on technical signals (domain setup, SSL, etc.), but these signals do not assess clinical quality or product effectiveness.
Critical note: These statements are from company insiders or supporters and do not constitute independent user reviews.
No formal, independently validated Triangle customer case studies reporting measurable clinical outcomes (for example, time-to-diagnosis, trial enrollment rates, or clinical endpoints) were located in available public sources.
Not applicable: Triangle is primarily a consumer-focused product in the materials reviewed.
Get a comprehensive analysis of Triangle including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Possible interpretations of the limited public footprint:
Critical evaluation: Absent independent validation, efficacy claims should be treated as unproven. The most defensible near-term value proposition is organizational (record consolidation and clarity) and informational (readability and question preparation) rather than demonstrated clinical outcome improvement.
Triangle Health ("Triangle") is a consumer-facing personal health record and AI-assisted navigation product that ingests a user’s medical documents, organizes them into a timeline, and provides plain-language explanations of standard-of-care and emerging treatment options (including clinical trials and experimental therapies). The product is designed to address fragmentation of medical records across portals/providers and to reduce the research burden on patients and caregivers when considering treatment decisions.
Core workflows described by the company:
Sources: Official vendor documentation and app store pages.
Primary target: Individuals and families dealing with complex, high-stakes diagnoses (the company’s public materials repeatedly reference oncology, clinical trials, and experimental treatments).
Secondary target: Chronic condition management more broadly (diabetes, autoimmune disease, heart disease, chronic pain, etc.) per public app store listing.
Positioning: The vendor describes the product as consumer-oriented "personal health navigation" rather than clinician-facing documentation or hospital IT tooling. Messaging aligns with a patient-facing care navigation layer on top of a personal health record.